Physician Search

Consuelo Wilkins, MD, MSCI, Senior Vice President for Health Equity and Inclusive Excellence for Vanderbilt University Medical Center (VUMC) and Senior Associate Dean for Health Equity and Inclusive Excellence for Vanderbilt University School of Medicine, always knew she wanted to be a physician. "Health equity was built into everything I did, even if I didn’t know it or recognize it at the time," Wilkins said. "I have always learned and believed that people are the same — everyone deserves to be healthy, and everyone should have the best opportunities to take care of themselves and their families." Click below to learn more about health equity initiatives.

https://momentum.vicc.org/2021/09/everyone-deserves-to-be-healthy/

Vanderbilt was the lead site for an NIH-funded, phase 2, multicenter influenza vaccine study in pediatric allogeneic hematopoietic stem cell transplant (HCT) recipients that may lead to a change in the current flu vaccine recommendations in this vulnerable population. Natasha Halasa, MD, MPH and colleagues recently published in the New England Journal of Medicine, that two doses of high-dose trivalent flu vaccine resulted in higher amounts of influenza-specific antibodies than two doses of standard dose quadrivalent vaccine.

https://news.vumc.org/2023/03/02/high-dose-flu-vaccine-beneficial-for-pediatric-stem-cell-transplant-patients/

Filter By:
Search by Keyword:

Displaying 81 - 90 of 288

Chemotherapy Levels in the Blood of Patients with Retinoblastoma

Retinoblastoma (Pediatrics)

Disease Sites: Retinoblastoma (Pediatrics)

Phase: N/A

Investigator: Daniels, Anthony

NCTID:

Protocol No: VICCREACH1792

Chemotherapy Levels in the Eyes of Patients with Retinoblastoma

Retinoblastoma (Pediatrics)

Disease Sites: Retinoblastoma (Pediatrics)

Phase: N/A

Investigator: Daniels, Anthony

NCTID:

Protocol No: VICCREACH17106

Developing Evidence-Based Criteria for Initiating Treatment for Neurofibromatosis Type 1 Associated Optic Pathway Glioma

Multiple Cancer Types

Disease Sites: Neuro-Oncology, Pediatrics

Phase: N/A

Investigator: Esbenshade, Adam

NCTID:

Protocol No: VICCPED17108

Optimization of Cancer Therapy Using Immune Effector Cells

Hematologic

Disease Sites: Hematologic

Phase: N/A

Investigator: Oluwole, Olalekan

NCTID:

Protocol No: VICCCTT1834

Integrating Comprehensive Precision Tobacco Treatment for Patients with Cancer

Miscellaneous

Disease Sites: Miscellaneous

Phase: N/A

Investigator: Tindle, Hilary

NCTID:

Protocol No: VICCTHO1886

Nashville Biosciences Blood Sample Collection Study

Multiple Cancer Types

Disease Sites: Colon, Liver, Lung, Non Small Cell, Ovarian, Pancreatic, Rectal

Phase: N/A

Investigator: Bernard, Gordon

NCTID:

Protocol No: VICCMD18123

COLON MAP: Colorectal Molecular Atlas Project

Colon

Disease Sites: Colon

Phase: N/A

Investigator: Shrubsole, Martha

NCTID:

Protocol No: VICCGI1905

Cancer Patient Safety Learning Laboratory (CaPSLL): Preventing Clinical Deterioration in Outpatients

Multiple Cancer Types

Disease Sites: Head/Neck, Lung

Phase: N/A

Investigator: Weinger, Matthew

NCTID:

Protocol No: VICCMD1998

A Quality Improvement Initiative to Prevent Venous Thromboembolism (VTE) Among Gynecologic Oncology Patients Undergoing Chemotherapy

Multiple Cancer Types

Disease Sites: Cervical, Gynecologic, Ovarian

Phase: N/A

Investigator: Brown, Alaina

NCTID:

Protocol No: VICCGYN19119

A Natural History Cohort Study of the Safety, Effectiveness, and Practice of Treatment for People with Severe Von Willebrand Disease (VWD)

Hematologic

Disease Sites: Hematologic

Phase: N/A

Investigator: Wheeler, Allison

NCTID:

Protocol No: VICCNCBH19121